ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 1,413 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 1,413 | -6.6% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 1,513 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -25.0% | 1,513 | -24.8% | 0.00% | – |
| Q4 2015 | $4,000 | – | 2,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |